Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Symptom Management and Survivorship Coaching for Advanced Cancer Patients and Caregivers

Official title: Symptom Management and Survivorship Plus Coaching to Reduce Symptom Severity and Improve Health Related-quality of Life (HR-QOL) for Breast, GI and Melanoma Cancer Survivors and Their Caregivers

Run by University of Arizona · NCT07415564 · Data updated 2026-11-12

This study tests a 10-week Symptom Management and Survivorship Handbook plus telephone coaching to help metastatic cancer patients and their caregivers manage symptoms and stay connected.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorUniversity of Arizona
Academic / other
Locations1 site (Tucson, Arizona)
StatusRecruiting
StartedMay 6, 2026
Main results expectedSeptember 2027
Study endsSeptember 2027
Registry record updatedJuly 20, 2026
Trial IDNCT07415564 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with metastatic/stage IV breast, GI, or melanoma cancer and a willing caregiver, English or Spanish speakers, and telephone access.

Probably not a fit

Patients without access to telephone or without a willing caregiver, or those already receiving a symptom management intervention, may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants include adults with metastatic or stage IV breast, GI, or melanoma cancer and their informal caregivers. All dyads receive the Symptom Management and Survivorship Handbook to guide symptom relief and survivorship needs, with the intervention arm receiving additional telephone health coaching to reduce symptom-related interference with daily life and social isolation. The program is delivered in English or Spanish and emphasizes scalable, information-driven support. Outcomes focus on symptom burden, quality of life, and caregiver well-being, with attention to marginalized populations who may experience greater isolation. Recruitment is centered at the University of Arizona Cancer Center in Tucson, under the lead sponsor University of Arizona.

Why it matters

Potential benefit: If successful, participants may experience reduced symptom burden and better quality of life, along with increased social support.

How similar studies have gone: Previous work suggests symptom management and coaching can reduce symptom burden and isolation, but this specific dyadic 10-week protocol is relatively novel in this patient population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria for cancer survivors:

* Age 18 or older
* Diagnosed with metastatic or stage IV breast, gastrointestinal (GI), and melanoma cancer
* Able to perform basic activities of daily living
* Cognitively oriented to time, place, and person (recruiter determined)
* Able to speak and understand English or Spanish
* Access to a telephone
* Has a caregiver in any relationship role (e.g., spouse, sibling, parent, friend) who can.

Inclusion criteria for the caregivers:

* Age 18 or older
* Able to speak and understand English or Spanish
* Telephone access
* Not currently treated for cancer

Exclusion criteria:

* Nursing home resident
* Bedridden
* Hospice care
* Currently receiving a symptom management intervention

Where it's running

  • University of Arizona Cancer Center
    Tucson, Arizona, United States
    Recruiting

Study contacts

  • Principal investigator: Terry A Badger, RN, PhD — University of Arizona College of Nursing
  • Study coordinator: Molly Hadeed, MPA, MSPH
  • Email: mcbarry@arizona.edu
  • Phone: 520-626-0583

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • IL-22BP mRNA peptide therapy for advanced solid tumors

    A phase 1 study tests a new peptide-delivered IL-22BP mRNA treatment to see if it is safe and if it has any early signs of shrinking or stopping advanced solid tumors in adults.

    Recruiting Phase 1 West China Hospital · Chengdu, Sichuan · NCT07583654

  • Comparing two types of radiation therapy for painful bone metastases

    This study is testing whether a new type of radiation therapy can help people with painful bone cancer feel better than the standard treatment.

    Recruiting at 12 sites Phase 3 Canadian Cancer Trials Group · Calgary, Alberta and 11 other locations · NCT06391242

  • Registry to monitor malnutrition in cancer patients

    This study is trying to see how tracking nutrition in newly diagnosed or treated cancer patients can help improve their health and quality of life.

    Recruiting at 13 sites Fondazione IRCCS Policlinico San Matteo di Pavia · Bari, BA and 15 other locations · NCT06337019

  • Long-term follow-up on cancer treatment effects and patient quality of life

    This study is trying to see how new cancer treatments affect patients' lives and well-being over time.

    Recruiting Institut Rafael · Levallois-Perret, Institut Rafael · NCT06317714

  • A tool to help young cancer patients manage their symptoms

    This study is testing a new computer tool to help young cancer patients better manage their symptoms during treatment.

    Recruiting at 4 sites Virginia Commonwealth University · Kansas City, Missouri and 4 other locations · NCT05958316

  • A support system for psychiatric diagnostics and follow-up

    This study is testing new self-assessment tools to help adults share information about their psychiatric symptoms so doctors can make better diagnoses and follow-ups.

    Recruiting at 5 sites Karolinska Institutet · Stockholm and 4 other locations · NCT05827406

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.